{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:36:02Z","timestamp":1791909362501,"version":"4.3.4"},"reference-count":27,"publisher":"American Society of Hematology","issue":"3","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2014,1,16]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Free light chain ratio, M-protein concentration, and immunosuppression predict progression of MGUS to lymphoid malignancies.<\/jats:p>","DOI":"10.1182\/blood-2013-05-505487","type":"journal-article","created":{"date-parts":[[2013,11,13]],"date-time":"2013-11-13T04:30:18Z","timestamp":1384317018000},"page":"338-345","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":126,"title":["Monoclonal gammopathy of undetermined significance and risk of lymphoid and myeloid malignancies: 728 cases followed up to 30 years in Sweden"],"prefix":"10.1182","volume":"123","author":[{"given":"Ingemar","family":"Turesson","sequence":"first","affiliation":[{"name":"Department of Hematology and Coagulation Disorders, Skane University Hospital, Malm\u00f6, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A.","family":"Kovalchik","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigurdur Y.","family":"Kristinsson","sequence":"additional","affiliation":[{"name":"Department of Hematology, Landspitali National University Hospital, Reykjavik, Iceland;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn R.","family":"Goldin","sequence":"additional","affiliation":[{"name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Drayson","sequence":"additional","affiliation":[{"name":"Clinical Immunology Service, University of Birmingham Medical School, Edgbaston, United Kingdom; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Landgren","sequence":"additional","affiliation":[{"name":"Multiple Myeloma Section, Metabolism Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111817135882300_B1","first-page":"211","article-title":"Studies on conditions associated with disturbed gamma globulin formation (gammopathies).","volume":"56","author":"Waldenstr\u00f6m","year":"1960-1961","journal-title":"Harvey Lect"},{"issue":"5","key":"2019111817135882300_B2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/0002-9343(78)90522-3","article-title":"Monoclonal gammopathy of undetermined significance. Natural history in 241 cases.","volume":"64","author":"Kyle","year":"1978","journal-title":"Am J Med"},{"issue":"5","key":"2019111817135882300_B3","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.","volume":"121","author":"International Myeloma Working Group","year":"2003","journal-title":"Br J Haematol"},{"issue":"24","key":"2019111817135882300_B4","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1056\/NEJM198006123022405","article-title":"Smoldering multiple myeloma.","volume":"302","author":"Kyle","year":"1980","journal-title":"N Engl J Med"},{"issue":"10","key":"2019111817135882300_B5","doi-asserted-by":"crossref","first-page":"945","DOI":"10.4065\/mcp.2010.0520","article-title":"Advances in the diagnosis, classification, risk stratification, and management of monoclonal gammopathy of undetermined significance: implications for recategorizing disease entities in the presence of evolving scientific evidence.","volume":"85","author":"Rajkumar","year":"2010","journal-title":"Mayo Clin Proc"},{"issue":"9727","key":"2019111817135882300_B6","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/S0140-6736(10)60482-5","article-title":"Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study.","volume":"375","author":"Dispenzieri","year":"2010","journal-title":"Lancet"},{"issue":"13","key":"2019111817135882300_B7","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111817135882300_B8","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"issue":"22","key":"2019111817135882300_B9","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"issue":"22","key":"2019111817135882300_B10","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients.","volume":"113","author":"Weiss","year":"2009","journal-title":"Blood"},{"issue":"8","key":"2019111817135882300_B11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"2019111817135882300_B12","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"issue":"7","key":"2019111817135882300_B13","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1182\/blood-2007-05-088443","article-title":"New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells.","volume":"110","author":"P\u00e9rez-Persona","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111817135882300_B14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00277-011-1293-1","article-title":"Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.","volume":"91","author":"Eisele","year":"2012","journal-title":"Ann Hematol"},{"key":"2019111817135882300_B15","volume-title":"Socialstyrelsen. Cancer Incidence in Sweden 2006","year":"2007"},{"issue":"10","key":"2019111817135882300_B16","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.22912","article-title":"Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003.","volume":"121","author":"Turesson","year":"2007","journal-title":"Int J Cancer"},{"key":"2019111817135882300_B17"},{"key":"2019111817135882300_B18","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk.","volume":"94(446)","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"2019111817135882300_B19","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","article-title":"Proportional hazards tests and diagnostics based on weighted residuals.","volume":"81(3)","author":"Grambsch","year":"1994","journal-title":"Biometrika"},{"issue":"15","key":"2019111817135882300_B20","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1093\/bioinformatics\/bti499","article-title":"Prediction error estimation: a comparison of resampling methods.","volume":"21","author":"Molinaro","year":"2005","journal-title":"Bioinformatics"},{"issue":"10","key":"2019111817135882300_B21","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1182\/blood-2003-03-0801","article-title":"Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.","volume":"102","author":"Kyle","year":"2003","journal-title":"Blood"},{"issue":"11","key":"2019111817135882300_B22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/ajh.21845","article-title":"IgM multiple myeloma: disease definition, prognosis, and differentiation from Waldenstrom\u2019s macroglobulinemia.","volume":"85","author":"Schuster","year":"2010","journal-title":"Am J Hematol"},{"issue":"3","key":"2019111817135882300_B23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"key":"2019111817135882300_B24","first-page":"1","article-title":"Metabolism of immunoglobulins.","volume":"13","author":"Waldmann","year":"1969","journal-title":"Prog Allergy"},{"issue":"6","key":"2019111817135882300_B25","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"issue":"1","key":"2019111817135882300_B26","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.1995.tb05256.x","article-title":"Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.","volume":"91","author":"van de Poel","year":"1995","journal-title":"Br J Haematol"},{"issue":"11","key":"2019111817135882300_B27","first-page":"1172","article-title":"The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.","volume":"86","author":"Gregersen","year":"2001","journal-title":"Haematologica"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/3\/338\/1377148\/338.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/123\/3\/338\/1377148\/338.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T22:14:14Z","timestamp":1574115254000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/123\/3\/338\/32296\/Monoclonal-gammopathy-of-undetermined-significance"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,16]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,1,16]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2013-05-505487","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,16]]}}}